BPCE
TEVA icon

Bank Pictet & Cie (Europe)’s Teva Pharmaceuticals TEVA Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,700,000
Closed -$28.2M – 261
2023
Q4 		$28.2M Buy
2,700,000
+1,350,000
+100% +$12.6M 0.84% 33
2023
Q3 		$13.8M Buy
+1,350,000
New +$12.6M 0.48% 50

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s TEVA Position: Q1 2024 in Review

Bank Pictet & Cie (Europe) sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 2,700,000 shares — an estimated $28.2M sold.

Bank Pictet & Cie (Europe) first reported a position in TEVA in Q3 2023 and held it in 2 quarters. The position peaked at $28.2M in Q4 2023. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Bank Pictet & Cie (Europe) reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 2,700,000 Teva Pharmaceuticals shares in Q1 2024, an estimated $28.2M.
  • Bank Pictet & Cie (Europe) first reported a position in Teva Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • Bank Pictet & Cie (Europe)'s Teva Pharmaceuticals position peaked at $28.2M in Q4 2023.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2024, filed 7 May 2024.